The global pharmaceutical contract
sales outsourcing (CSO) market involves sales and marketing outsourcing
services provided by contract sales organizations to pharmaceutical companies.
CSOs help pharmaceutical companies in promoting their drugs to healthcare
professionals through their field sales teams. The services provided include sales
force optimization, mapping physician networks, data analytics for sales force
effectiveness, and ensuring product availability through distribution channels.
The pharmaceutical CSO market is driven by the need to optimize sales and
marketing costs for pharmaceutical companies. Outsourcing non-core sales and
marketing functions allows pharma companies to focus on drug research and
development.
The global pharmaceutical CSO market
is estimated to be valued at US$ 8,599.2
Mn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global
Pharmaceutical Contract Sales Outsourcing Size are IQVIA Inc., Syneos
Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis
Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs
Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions.
IQVIA Inc. and Syneos Health Inc. dominate the market with their comprehensive
CSO service offerings.
Key opportunities in the pharmaceutical CSO market include expanding service
portfolios to provide integrated medical solutions covering both sales and
marketing functions. With patent cliffs impacting major drugs, CSOs can help
launch generic and biosimilar versions of off-patent drugs in international
markets. There is growth potential in emerging markets of Asia Pacific, Middle East,
and Latin America driven by increasing healthcare spends and demand for
specialty drugs in these regions. CSO players are pursuing global expansion
strategies through acquisitions and partnerships to solidify their presence
across markets.
Market drivers and restrain
The key driver for the
pharmaceutical CSO market is the need for pharmaceutical companies to optimize
sales and marketing costs. Outsourcing non-core commercial operations to
specialized CSO players allows pharma companies to focus on drug research and
development. This helps reduce fixed costs associated with maintaining in-house
sales teams. Additionally, CSOs offer data-driven scientific services and
specialized therapeutic expertise that enhance sales force effectiveness.
A major restraint is the risk of over-dependence on CSO partners for commercial
sales operations. Critical sales visibility and control may shift to CSO
players due to outsourcing of major marketing functions. Pharma companies also
lose direct oversight and management of field sales representatives.
Contractual compliances and ensuring service level agreements also remain
important challenges. Additionally, frequent mergers and acquisitions among top
CSO players result in shifts in organizational structures and account teams
that impact client relationships.
Segment Analysis
The generic drugs sub segment
dominates the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market.
Generic drugs have lower costs compared to branded drugs providing higher
affordability and accessibility to patients worldwide. The patent expiries of
many blockbuster drugs and growing prevalence of chronic diseases are
compelling big pharmaceutical companies to outsource sales and marketing of
generic drugs to specialist CSO companies. These specialist companies focus on
sales promotion and maximizing the market potential of off-patent generic drugs
through their extensive sales networks and sales teams.
Regional Analysis
North America is expected to remain
the fastest growing and dominating regional market for pharmaceutical contract
sales outsourcing during the forecast period. High healthcare expenditure,
presence of many big pharmaceutical companies, patent cliffs forcing increased
reliance on biosimilars and generics, growing adoption of specialized CSO
services are some key factors driving the North American pharmaceutical CSO
market growth. The United States accounts for the major share of the North
American as well as global pharmaceutical CSO market owing to the large size of
its pharmaceutical industry and healthcare market.
Gets
More Insights on: Global
Pharmaceutical Contract Sales Outsourcing Market
Explore
More Related Topic: Scaffold
technology
Comments
Post a Comment